skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands

Authors:
 [1];  [1];  [1];  [2];  [3];  [4];  [1];  [5];  [4];  [2]; ORCiD logo [1]
  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA USA
  2. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston MA USA
  3. Department of Systems Biology, Harvard Medical School, Boston MA USA; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton NJ USA
  4. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA USA
  5. Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton NJ USA; Department of Molecular Biology, Princeton University, Princeton NJ USA
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC)
OSTI Identifier:
1430336
Resource Type:
Journal Article
Journal Name:
Angewandte Chemie (International Edition)
Additional Journal Information:
Journal Volume: 56; Journal Issue: 21; Journal ID: ISSN 1433-7851
Publisher:
Wiley
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Remillard, David, Buckley, Dennis L., Paulk, Joshiawa, Brien, Gerard L., Sonnett, Matthew, Seo, Hyuk-Soo, Dastjerdi, Shiva, Wühr, Martin, Dhe-Paganon, Sirano, Armstrong, Scott A., and Bradner, James E. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. United States: N. p., 2017. Web. doi:10.1002/anie.201611281.
Remillard, David, Buckley, Dennis L., Paulk, Joshiawa, Brien, Gerard L., Sonnett, Matthew, Seo, Hyuk-Soo, Dastjerdi, Shiva, Wühr, Martin, Dhe-Paganon, Sirano, Armstrong, Scott A., & Bradner, James E. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands. United States. doi:10.1002/anie.201611281.
Remillard, David, Buckley, Dennis L., Paulk, Joshiawa, Brien, Gerard L., Sonnett, Matthew, Seo, Hyuk-Soo, Dastjerdi, Shiva, Wühr, Martin, Dhe-Paganon, Sirano, Armstrong, Scott A., and Bradner, James E. Tue . "Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands". United States. doi:10.1002/anie.201611281.
@article{osti_1430336,
title = {Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands},
author = {Remillard, David and Buckley, Dennis L. and Paulk, Joshiawa and Brien, Gerard L. and Sonnett, Matthew and Seo, Hyuk-Soo and Dastjerdi, Shiva and Wühr, Martin and Dhe-Paganon, Sirano and Armstrong, Scott A. and Bradner, James E.},
abstractNote = {},
doi = {10.1002/anie.201611281},
journal = {Angewandte Chemie (International Edition)},
issn = {1433-7851},
number = 21,
volume = 56,
place = {United States},
year = {2017},
month = {4}
}

Works referenced in this record:

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
journal, June 2015


The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
journal, July 2015


Clinical progress and pharmacology of small molecule bromodomain inhibitors
journal, August 2016

  • Theodoulou, Natalie H.; Tomkinson, Nicholas CO; Prinjha, Rab K.
  • Current Opinion in Chemical Biology, Vol. 33
  • DOI: 10.1016/j.cbpa.2016.05.028

Chemical Genetic Control of Protein Levels:  Selective in Vivo Targeted Degradation
journal, March 2004

  • Schneekloth,, John S.; Fonseca, Fabiana N.; Koldobskiy, Michael
  • Journal of the American Chemical Society, Vol. 126, Issue 12
  • DOI: 10.1021/ja039025z

Selective inhibition of BET bromodomains
journal, September 2010

  • Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah
  • Nature, Vol. 468, Issue 7327
  • DOI: 10.1038/nature09504

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
journal, April 2015

  • Clark, Peter G. K.; Vieira, Lucas C. C.; Tallant, Cynthia
  • Angewandte Chemie, Vol. 127, Issue 21
  • DOI: 10.1002/ange.201501394

9 H -Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
journal, February 2015

  • Picaud, Sarah; Strocchia, Maria; Terracciano, Stefania
  • Journal of Medicinal Chemistry, Vol. 58, Issue 6
  • DOI: 10.1021/jm501893k

The Bromodomain: A New Target in Emerging Epigenetic Medicine
journal, December 2015


Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
journal, July 2001

  • Sakamoto, K. M.; Kim, K. B.; Kumagai, A.
  • Proceedings of the National Academy of Sciences, Vol. 98, Issue 15
  • DOI: 10.1073/pnas.141230798

Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography
journal, January 2014

  • Guetzoyan, Lucie; Ingham, Richard J.; Nikbin, Nikzad
  • Med. Chem. Commun., Vol. 5, Issue 4
  • DOI: 10.1039/C4MD00007B

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
journal, April 2015

  • Clark, Peter G. K.; Vieira, Lucas C. C.; Tallant, Cynthia
  • Angewandte Chemie International Edition, Vol. 54, Issue 21
  • DOI: 10.1002/anie.201501394

Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
journal, November 2015

  • Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris
  • Angewandte Chemie International Edition, Vol. 55, Issue 2
  • DOI: 10.1002/anie.201507634

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
journal, March 2016


Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
journal, March 2015


Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence
journal, February 2015

  • Chaidos, Aristeidis; Caputo, Valentina; Karadimitris, Anastasios
  • Therapeutic Advances in Hematology, Vol. 6, Issue 3
  • DOI: 10.1177/2040620715576662

Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
journal, March 2013


Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
journal, April 2015

  • Theodoulou, Natalie H.; Bamborough, Paul; Bannister, Andrew J.
  • Journal of Medicinal Chemistry, Vol. 59, Issue 4
  • DOI: 10.1021/acs.jmedchem.5b00256

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
journal, June 2016

  • Raina, Kanak; Lu, Jing; Qian, Yimin
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 26
  • DOI: 10.1073/pnas.1521738113

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
journal, November 2013


Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
journal, July 2016

  • Hohmann, Anja F.; Martin, Laetitia J.; Minder, Jessica L.
  • Nature Chemical Biology, Vol. 12, Issue 9
  • DOI: 10.1038/nchembio.2115

A Comprehensive Mathematical Model for Three-Body Binding Equilibria
journal, April 2013

  • Douglass, Eugene F.; Miller, Chad J.; Sparer, Gerson
  • Journal of the American Chemical Society, Vol. 135, Issue 16
  • DOI: 10.1021/ja311795d

Targeting bromodomains: epigenetic readers of lysine acetylation
journal, April 2014

  • Filippakopoulos, Panagis; Knapp, Stefan
  • Nature Reviews Drug Discovery, Vol. 13, Issue 5
  • DOI: 10.1038/nrd4286

Phthalimide conjugation as a strategy for in vivo target protein degradation
journal, May 2015


Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
journal, May 2013

  • Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney
  • Nature Genetics, Vol. 45, Issue 6
  • DOI: 10.1038/ng.2628

Structural Insights into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of Conjugation
journal, September 2008


MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes
journal, July 2014

  • McAlister, Graeme C.; Nusinow, David P.; Jedrychowski, Mark P.
  • Analytical Chemistry, Vol. 86, Issue 14
  • DOI: 10.1021/ac502040v

Suppression of inflammation by a synthetic histone mimic
journal, November 2010

  • Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe
  • Nature, Vol. 468, Issue 7327
  • DOI: 10.1038/nature09589

Modulares PROTAC-Design zum Abbau von onkogenem BCR-ABL
journal, November 2015

  • Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris
  • Angewandte Chemie, Vol. 128, Issue 2
  • DOI: 10.1002/ange.201507634

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
journal, April 2009

  • Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.
  • Nature, Vol. 458, Issue 7239
  • DOI: 10.1038/nature07884